| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
| mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |